Sulodexide to prevent psoriasis return after stopping biologic
Part of Skin clinical trials.
This trial tests if sulodexide, a medication that helps blood flow, can keep psoriasis from coming back after you have stopped using a biologic drug (such as strychnicolizumab) because your skin was completely clear for 6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have moderate to severe plaque psoriasis.
- You have taken a biologic called strychnicolizumab for at least 3 months, your skin became fully clear, and you have stayed clear for 6 months while on the biologic.
- You are now ready to stop the biologic according to standard guidelines.
- You have not had a serious infection or bleeding disorder recently.
- You are not pregnant, planning pregnancy, or breastfeeding during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at patients with moderate-to-severe psoriasis who have already responded well to secukinumab (an injection that targets the immune system). Researchers want to see which maintenance dosing schedule works best long-term and causes the fewest side effects.
This trial tests an investigational drug, HB0017, in adults with moderate to severe plaque psoriasis. If you have had psoriasis for at least 6 months and have not used certain biologic treatments, you may be able to join.
This study tests whether two common blood-thinning medicines, aspirin and clopidogrel, can help reduce inflammation and symptoms in people with psoriasis or psoriatic arthritis. If you have psoriasis or psoriatic arthritis and are not already on blood thinners, you might be able to join.
This Phase 4 study looks at how well a psoriasis medicine called secukinumab works, and what happens when treatment is stopped in people with moderate-to-severe plaque psoriasis. It may help show the best way to manage symptoms and prevent flare-ups.
This study compares a proactive approach (adjusting drug levels based on regular blood tests) versus the usual way of using biologics for psoriasis. It helps see if active monitoring can improve treatment while keeping you safe.
This study looks at how well ixekizumab (an injection medication) works for moderate-to-severe plaque psoriasis, and what happens when the treatment is withdrawn. It may help you learn whether stopping the medicine is safe and how skin disease outcomes change over time.
Hear when a new Psoriasis (PsO) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.